ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues

Publisher： Karger

E-ISSN： 1423-0194|105|3|295-309

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.105, Iss.3, 2017-04, pp. : 295-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs

By  

Neuroendocrinology, Vol. 90, Iss. 2, 2009-08 ,pp. : 220-226

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy

By  

Neuroendocrinology, Vol. 105, Iss. 3, 2017-04 ,pp. : 281-294

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with 111In-Pentetreotide

By  

Neuroendocrinology, Vol. 90, Iss. 2, 2009-08 ,pp. : 184-189

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents

By  

Neuroendocrinology, Vol. 105, Iss. 3, 2017-03 ,pp. : 266-280

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 105, Iss. 3, 2017-02 ,pp. : 193-195

Karger

Access to resources Recommend Favorite